Crossmark

Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study

Crossref DOI link: https://doi.org/10.1245/s10434-022-12969-0

Published Online: 2022-12-24

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dietz, Michelle V.

Ziekman, Merijn J.

van Kooten, Job P.

Brandt-Kerkhof, Alexandra R. M.

van Meerten, Esther

Verhoef, Cornelis

Madsen, Eva V. E.
License Information

Text and Data Mining valid from 2022-12-24

Version of Record valid from 2022-12-24
More Information

Article History

Received: 24 June 2022

Accepted: 8 December 2022

First Online: 24 December 2022

Disclosure

: There are no conflicts of interest.

Document is current

Any future updates will be listed below